Search results for abx831484

Cemiplimab, Abbexa, abx831484

Cemiplimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Cemiplimab is a fully human PD-1 antibody. The first indication for the marketing application is metastatic/locally advanced cutaneous squamous cell carcinoma (Cutaneous Squamous Cell Carcinoma, CSCC). It is an intravenous immunotherapy targeting the PD-1 pathway, which can help the immune system fight cancer cells.